Testing effectiveness (Phase 2)Looking for participantsNCT07549503
What this trial is testing
Early Signals of the Transition From Immune Quiescence to Activation in the Liver Allograft Microenvironment and in the Circulation
Who this might be right for
Liver Transplant
National Institute of Allergy and Infectious Diseases (NIAID) 100